What is Type1Screen?
Type1Screen offers antibody testing to children and young adults to determine if they are at risk of developing type 1 diabetes.
People who are found to test positive are monitored closely and, if they develop type 1 diabetes, will be started on insulin early to avoid serious illness.
Type1Screen also offers opportunities to participate in clinical trials and other research that aims to prevent type 1 diabetes.
Why screen for T1D?
A blood test for antibodies clarifies whether you, or your child, are at risk of developing type 1 diabetes.
A negative test provides reassurance that the risk of diabetes is low. Two or more positive tests signal a need to look out for symptoms of diabetes so that we can help you start insulin treatment before serious illness develops.
People with antibodies may be eligible to participate in clinical trials that aim to prevent or delay the development of type 1 diabetes.
By joining the Type1Screen community, you will have access to current, authoritative information about type 1 diabetes treatment and prevention. Your involvement will make an important contribution to our quest for a cure.
Is this of interest? Find out more.
Who is working with Type1Screen?
The lead doctors for Type1Screen are Peter Colman and John Wentworth (pictured above), who work at The Royal Melbourne Hospital.
However, Type1Screen involves a network of doctors, nurses, researchers and scientists, across Australia and New Zealand. They are all working very hard to find a way to turn type one into type none.